PPARG and amyloidosis: They can activate PPAR‐γ, which are expressed in various regions of the brain, regulating a range of activities that positively influence the pathology of Alzheimer's disease, including reducing insulin resistance, inhibiting inflammation, improving mitochondrial function, and reducing tau and amyloid pathology.9, 30, 31